Akorn Pharmaceuticals

Akorn Investor Relations

SEC Filings

Filing date Form Description Filing Group View
SC 13G/A

An amendment to the SC 13G filing

3,4,5
SC 13G/A

An amendment to the SC 13G filing

3,4,5
NT 10-K

Notification that form 10-K will be submitted late

Annual Filings
8-K

Report of unscheduled material events or corporate event

Current Reports
NT 10-Q

Notification that form type 10-Q will be submitted late

Quarterly Filings
10-Q/A

Amendment to a previously filed 10-Q

Quarterly Filings
10-Q/A

Amendment to a previously filed 10-Q

Quarterly Filings
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
8-K/A

Amendment to a previously filed 8-K

Current Reports